You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

COVID-19: Get the latest updates or take a self-assessment.

Guidelines & Advice
About Guidelines Email Guidelines Team

Patient Indications for Mohs Micrographic Surgery

ID: GL 8-11 Jan 2018
Type of Content: Guidelines & Advice, Clinical
Document Status: Current
Authors:
C. Murray, D. Sivajohanathan, T. Hanna, S. Bradshaw, N. Solish, B. Moran, R. Hekkenberg, A. Wei, T. Petrella, The Melanoma Disease Site Group

Guideline Objective

  1. To describe evidence-based indications for Mohs micrographic surgery (MMS);
  2. To assess Mohs outcomes such as cure rates and recurrence rates, as well as quality of life (QOL) and complications;
  3. To assess whether volume of patients treated affects outcomes of MMS.

Patient Population

Adults with a diagnosis of skin cancer.

Intended Guideline Users

Clinicians involved in the assessment and treatment of patients with skin cancer.

Research Questions

  1. Does MMS provide better outcomes than WLE in patients with skin cancer?
    1. Cure rates, recurrence rates
    2. QOL
    3. Complications, cosmesis
  2. In patients with skin cancer, what are the clinical characteristics or indications that identify groups of patients who derive greater benefit from MMS?
  3. Does MMS provide better outcomes than radiation in patients with skin cancer?
    1. Cure rates, recurrence rates
    2. QOL
    3. Complications, cosmesis
  4. Does WLE provide better outcomes than radiation in patients with skin cancer?
    1. Cure rates, recurrence rates
    2. QOL
    3. Complications, cosmesis
  5. Does surgical volume of MMS predict for better outcomes in patients with skin cancer?
pdf download Summary (PDF) (188.31 KB)
pdf download Full Report (PDF) (876.06 KB)